{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T04:43:37Z","timestamp":1648874617178},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T00:00:00Z","timestamp":1286323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00101-010-1797-4","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T13:21:54Z","timestamp":1286198514000},"page":"1135-1140","source":"Crossref","is-referenced-by-count":2,"title":["Management einer komplexen Thrombozytopenie mithilfe der Thrombelastometrie"],"prefix":"10.1007","volume":"60","author":[{"given":"H.A.","family":"Haeberle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Unertl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Noh\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"key":"1797_CR1","doi-asserted-by":"crossref","unstructured":"Anderson D, Ali K, Blanchette V et al (2007) Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus Med Rev 21 [2 Supppl 1]:9\u201356","DOI":"10.1016\/j.tmrv.2007.01.001"},{"key":"1797_CR2","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/01.CCM.0000147769.07699.E3","volume":"32","author":"Bakhtiari","year":"2004","unstructured":"Bakhtiari K, Meijers JC, Jonge E de, Levi M (2004) Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32:2416\u20132421","journal-title":"Crit Care Med"},{"key":"1797_CR3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1345\/aph.1H569","volume":"41","author":"Beiderlinden","year":"2007","unstructured":"Beiderlinden M, Treschan TA, Gorlinger K, Peters J (2007) Argatroban anticoagulation in critically ill patients. Ann Pharmacother 41:749\u2013754","journal-title":"Ann Pharmacother"},{"key":"1797_CR4","unstructured":"Kiefel V (2010) Thrombozytenbildungs-, Abbau- und Verteilungsst\u00f6rungen. In: P\u00f6tzsch B, Madlener K (Hrsg) H\u00e4mostaseologie. Springer, Berlin Heidelberg New York Tokio, S\u00a0306\u2013318"},{"key":"1797_CR5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1213\/ane.0b013e3181966675","volume":"108","author":"Lang","year":"2009","unstructured":"Lang T, Johanning K, Metzler H et al (2009) The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 108:751\u2013758","journal-title":"Anesth Analg"},{"key":"1797_CR6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ALN.0b013e31817885b7","volume":"109","author":"Molinaro","year":"2008","unstructured":"Molinaro RJ, Szlam F, Levy JH et al (2008) Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin. Anesthesiology 109:160\u2013161","journal-title":"Anesthesiology"},{"key":"1797_CR7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/bja\/aep089","volume":"102","author":"Rahe-Meyer","year":"2009","unstructured":"Rahe-Meyer N, Pichlmaier M, Haverich A et al (2009) Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 102:785\u2013792","journal-title":"Br J Anaesth"},{"key":"1797_CR8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jtcvs.2008.11.065","volume":"138","author":"Rahe-Meyer","year":"2009","unstructured":"Rahe-Meyer N, Solomon C, Winterhalter M et al (2009) Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 138:694\u2013702","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1797_CR9","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/01.CCM.0000259538.02375.A5","volume":"35","author":"Selleng","year":"2007","unstructured":"Selleng K, Warkentin TE, Greinacher A (2007) Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35:1165\u20131176","journal-title":"Crit Care Med"},{"key":"1797_CR10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MBC.0b013e3282fe73ec","volume":"19","author":"Siegmund","year":"2008","unstructured":"Siegmund R, Boer K, Poeschel K et al (2008) Influence of direct thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation therapy and patients with liver dysfunction. Blood Coagul Fibrinolysis 19:288\u2013293","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1797_CR11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2007.02481.x","volume":"5","author":"Velik-Salchner","year":"2007","unstructured":"Velik-Salchner C, Haas T, Innerhofer P et al (2007) The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 5:1019\u20131025","journal-title":"J Thromb Haemost"},{"key":"1797_CR12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1160\/TH05-03-0154","volume":"94","author":"Warkentin","year":"2005","unstructured":"Warkentin TE, Greinacher A, Craven S et al (2005) Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation. Thromb Haemost 94:958\u2013964","journal-title":"Thromb Haemost"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-010-1797-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-010-1797-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-010-1797-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T06:03:00Z","timestamp":1559714580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-010-1797-4"}},"subtitle":["Koinzidenz von posttransfusioneller Purpura und Heparin-induzierter Thrombozytopenie"],"short-title":[],"issued":{"date-parts":[[2010,10,6]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1007\/s00101-010-1797-4","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,6]]}}}